Schoof Lauritz, Lemoine Marc D, Söffker Gerold, Rillig Andreas, Kany Shinwan
Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg 20246, Germany.
University Center of Cardiovascular Science, University Medical Center Hamburg Eppendorf, Martinistraße 52, Hamburg 20246, Germany.
Eur Heart J Case Rep. 2025 Aug 11;9(8):ytaf373. doi: 10.1093/ehjcr/ytaf373. eCollection 2025 Aug.
Atrial fibrillation (AF) can be associated with acute heart failure (HF) and can complicate cardiogenic shock. The interaction between AF and HF is challenging, both diagnostically and therapeutically. While AF ablation has been shown to be beneficial in patients with HF, the role of interventional treatment of AF in acute HF remains largely unexplored.
A 59-year-old male patient was admitted from an outside hospital after a prolonged intensive care stay developing acute respiratory failure with concomitant acute HF. Previously, the patient experienced a cardiogenic shock after a non-synchronized cardioversion that induced ventricular fibrillation at the end of an AF ablation procedure. After initial improvement, he was transferred to a rehabilitation hospital where he showed signs of respiratory failure and HF. Upon transfer to our hospital, a veno-arterial-venous extracorporeal membrane oxygenation (VAV-ECMO) device was implanted in addition to diuretic and inotropic therapy. While the respiratory function steadily improved, allowing de-escalation to a VV-ECMO device, recurrent episodes of AF with rapid ventricular rate were observed. This resulted in a severely reduced biventricular function despite antiarrhythmic therapy with amiodarone. We opted for pulsed field ablation (PFA) of the pulmonary veins, which finally enabled us to explant the ECMO system under sustained sinus rhythm and improved haemodynamics. An echocardiographic assessment 3 weeks post-ablation demonstrated improved cardiac function and maintained sinus rhythm.
This case illustrates the complexities of treating patients with acute HF and AF. Our experience highlights the value of the fast, efficient, and safe PFA modality for ablation in critically ill patients.
心房颤动(AF)可与急性心力衰竭(HF)相关,并可使心源性休克复杂化。AF与HF之间的相互作用在诊断和治疗方面都具有挑战性。虽然AF消融已被证明对HF患者有益,但AF介入治疗在急性HF中的作用在很大程度上仍未得到探索。
一名59岁男性患者在长时间重症监护后从外院转入,出现急性呼吸衰竭并伴有急性HF。此前,该患者在一次非同步心脏复律后发生心源性休克,该复律在AF消融手术结束时诱发了室颤。经过初步改善后,他被转至一家康复医院,在那里他出现了呼吸衰竭和HF的症状。转入我院后,除了利尿剂和强心治疗外,还植入了静脉-动脉-静脉体外膜肺氧合(VAV-ECMO)装置。虽然呼吸功能稳步改善,允许降级至VV-ECMO装置,但仍观察到AF伴快速心室率的反复发作。尽管使用胺碘酮进行抗心律失常治疗,但这导致双心室功能严重降低。我们选择了肺静脉脉冲场消融(PFA),最终使我们能够在持续窦性心律和改善的血流动力学情况下移除ECMO系统。消融术后3周的超声心动图评估显示心脏功能改善且窦性心律维持。
本病例说明了治疗急性HF和AF患者的复杂性。我们的经验强调了快速、高效和安全的PFA模式在危重症患者消融中的价值。